miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT-Reference-Cited by-同舟云学术

miR-375 Mediated Acquired Chemo-Resistance in Cervical Cancer by Facilitating EMT

Published:2014-10-16 Issue:10 Volume:9 Page:e109299
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Shen Yuanming,Zhou Jiansong,Li Yang,Ye Feng,Wan Xiaoyun,Lu Weiguo,Xie Xing,Cheng Xiaodong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy;L Adam;Clin Cancer Res,2009

2. Epithelial-mesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease;S Cannito;Antioxid Redox Signal,2010

3. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance;Z Wang;Drug Resist Updat,2010

4. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines;AD Yang;Clin Cancer Res,2006

5. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells;H Kajiyama;Int J Oncol,2007

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses;Frontiers in Cell and Developmental Biology;2024-08-28

2. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response;Cancer and Metastasis Reviews;2024-01-16

3. MicroRNA involvement in cervical cancer chemotherapy drug resistance: Restoring sensitivity to chemotherapeutic drugs;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

4. Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer;npj Precision Oncology;2023-12-08

5. MiR-375 promotes cisplatin sensitivity of lung adenocarcinoma;Pathology - Research and Practice;2023-09